SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001274644-17-000025
Filing Date
2017-03-31
Accepted
2017-03-31 16:02:37
Documents
3
Period of Report
2017-03-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ocera-8xkmarch312017employ.htm 8-K 38845
2 EXHIBIT 10.1 ocera-amendmenttograisempl.htm EX-10.1 22111
3 EXHIBIT 10.2 ocera-amendmenttobyrnesemp.htm EX-10.2 27162
  Complete submission text file 0001274644-17-000025.txt   89456
Mailing Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94063
Business Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94063 650-475-0158
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 17730292
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences